The combination of the GFAP, NfL, and p-tau 181 yielded a higher AUC value (0.528) than that for any single plasma biomarker, and after adding clinical indicators of AD, the AUC value for the three proteins was estimated at 0.54. This evidence concerns the gene GFAP and Alzheimer disease.